Kezar Life Sciences, Inc. (KZR)
NASDAQ: KZR · Real-Time Price · USD
6.36
+0.03 (0.47%)
Dec 24, 2025, 1:00 PM EST - Market closed
Kezar Life Sciences Market Cap
Kezar Life Sciences has a market cap or net worth of $46.43 million as of December 24, 2025. Its market cap has decreased by -8.44% in one year.
Market Cap
46.43M
Enterprise Value
-33.88M
1-Year Change
-8.44%
Ranking
Category
Stock Price
$6.36
Market Cap Chart
Since June 21, 2018, Kezar Life Sciences's market cap has decreased from $325.21M to $46.43M, a decrease of -85.72%. That is a compound annual growth rate of -22.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 46.43M | -5.31% |
| Dec 31, 2024 | 49.03M | -28.81% |
| Dec 29, 2023 | 68.87M | -85.69% |
| Dec 30, 2022 | 481.38M | -41.42% |
| Dec 31, 2021 | 821.73M | 240.23% |
| Dec 31, 2020 | 241.52M | 214.65% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 21, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 953.05B |
| Johnson & Johnson | 497.52B |
| AbbVie | 399.61B |
| UnitedHealth Group | 297.39B |
| AstraZeneca | 283.55B |
| Novartis AG | 261.76B |
| Merck & Co. | 255.21B |
| Abbott Laboratories | 219.49B |